BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 11245462)

  • 21. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils.
    Zhang JP; Wong CK; Lam CW
    Clin Exp Immunol; 2000 Oct; 122(1):20-7. PubMed ID: 11012613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
    Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
    Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
    Chuang SM; Liou GY; Yang JL
    Carcinogenesis; 2000 Aug; 21(8):1491-500. PubMed ID: 10910949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
    Hu Y; Bally M; Dragowska WH; Mayer L
    Mol Cancer Ther; 2003 Jul; 2(7):641-9. PubMed ID: 12883037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK).
    Byon JC; Dadke SS; Rulli S; Kusari AB; Kusari J
    Mol Cell Biochem; 2001 Feb; 218(1-2):131-8. PubMed ID: 11330828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
    Morgan MA; Dolp O; Reuter CW
    Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of MAPK activities associated with intestinal cell differentiation.
    Ding Q; Wang Q; Evers BM
    Biochem Biophys Res Commun; 2001 Jun; 284(2):282-8. PubMed ID: 11394874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival.
    Wang X; Martindale JL; Liu Y; Holbrook NJ
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):291-300. PubMed ID: 9657968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway.
    Ohtsuka T; Buchsbaum D; Oliver P; Makhija S; Kimberly R; Zhou T
    Oncogene; 2003 Apr; 22(13):2034-44. PubMed ID: 12673208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
    Yu C; Rahmani M; Dent P; Grant S
    Exp Cell Res; 2004 May; 295(2):555-66. PubMed ID: 15093752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
    Ding XZ; Adrian TE
    Biochem Biophys Res Commun; 2001 Mar; 282(2):447-53. PubMed ID: 11401480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death.
    Sarker KP; Biswas KK; Yamakuchi M; Lee KY; Hahiguchi T; Kracht M; Kitajima I; Maruyama I
    J Neurochem; 2003 Apr; 85(1):50-61. PubMed ID: 12641726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEK and p38MAPK inhibitors potentiate TNF-alpha induced apoptosis in U937 cells.
    Nakada S; Kawano T; Saito-akita S; Iwase S; Horiguchi-Yamada J; Ohno T; Yamada H
    Anticancer Res; 2001; 21(1A):167-71. PubMed ID: 11299730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
    Shinohara H; Yagita H; Ikawa Y; Oyaizu N
    Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.